期刊文献+

肼苯哒嗪对宫颈癌细胞系APC基因异常甲基化的影响 被引量:6

Effect of Hydralazine on the methylation of APC in cervical carcinoma cell lines
下载PDF
导出
摘要 目的检测宫颈癌细胞系HeLa、CaSki和SiHa中结肠腺瘤性息肉病基因(APC)启动子区CpG岛甲基化状态;探索肼苯哒嗪(Hyd)能否作为去甲基化药物恢复APC表达。方法应用甲基化特异性聚合酶链反应(MSP)检测细胞系中APC启动子区CpG岛甲基化情况;Hyd处理后,RT-PCR检测APCmRNA表达。结果APC启动子区CpG岛在HeLa细胞中被甲基化,在CaSki细胞中半甲基化,在SiHa细胞中无甲基化;一定浓度Hyd处理HeLa、CaSki细胞后,检测到APCmRNA表达。结论HeLa、CaSki细胞系APC表达沉默与APC启动子区甲基化有关;Hyd能作为去甲基化药物诱导APC表达。 Objective To detect 5'CpG island methylation in cervical carcinoma cell lines (HeLa, CaSki, SiHa), and of APC ( adenomatous polyposis coli ) gene promoter region to investigate the possibility of Hydralazine in restoring the expression of APC gene through demethylation. Methods The CpG island methylation status of APC gene promoter region of the cervical carcinoma cell lines were analyzed using methylated specific polymerase chain reaction (MSP). The mRNA expression profile of APC gene was analyzed by using RT-PCR after Hydralazine treatment. Results The CpG island of APC gene was methylated in HeLa and hemimethylated in CaSki but not in SiHa. The mRNA expression of APC gene can be detected after hydralazine treatment. Conclusion The APC gene non-expression in cervical carcinoma is associated with CpG island methylation in APC gene promoter region. Hydralazine, served as a demethylating agent, enables to restore the expression of APC gene.
出处 《基础医学与临床》 CSCD 北大核心 2007年第9期981-984,共4页 Basic and Clinical Medicine
基金 湖北省卫生厅科研基金(JX2B76)
关键词 宫颈癌 APC DNA甲基化 肼苯哒嗪 cervical carcinoma APC DNA methylation hydralazine
  • 相关文献

参考文献8

  • 1环奕.WNT信号通路与肿瘤[J].基础医学与临床,2006,26(8):922-925. 被引量:17
  • 2Yang Y, Takeuchi S, Tsukasaki K, et al. Methylation analysis of the adenomatous polyposis coli (APC) gene in adult T-cell leukemia/lymphoma [ J ]. Leuk Res, 2005,29 ( 1 ) : 47 -51.
  • 3Zysman M, Saka A, Millar A, et al. Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype [ J ]. Cancer Res,2002,62 ( 13 ) : 3663 - 3666.
  • 4Zambrano P, Segura-Pacheco B, Perez-Cardenas E, et al. A phase I study of Hydralazine to demethylate and reactivate the expression of tumor suppressor genes [ J ]. BMC Cancer, 2005,5( 1 ) :44 -55.
  • 5杨宇霞,孔祥东,张思仲.原发胃癌中p16和p15基因表达及甲基化异常[J].基础医学与临床,2002,22(4):318-323. 被引量:4
  • 6Dong SM, Kim HS, Rha SH, et al. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix [J]. Clin Cancer Res,2001,7(7) :1982 - 1986.
  • 7Segura-Pacheco B, Trejo-Becerril C, Perez-Cardenas E, et al. Reactivation of tumor suppressor genes by the cardiovascular drugs Hydralazine and procainamide and their potential use in cancer therapy [ J ]. Clin Cancer Res, 2003,9 (5) :1596 - 1603.
  • 8Chavez-Blanco A, Perez-Plasencia C, Perez-Cardenas E, et al. Antineoplastic effects of the DNA methylation inhibitor Hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines[J]. Cancer Cell Int,2006 ,6 :2.

二级参考文献22

  • 1[1]Kamb A, Gruis NA, Weaver-Feldhaus J. A cell cycle regulator potentially involved in genesis of many tumor types[J]. Science, 1994, 264(5157):436-440.
  • 2[2]Zhao Y, Zhang S, Fu B, et al.Abnormalities of tumor suppressor genes P16 and P15 in primary maxillofacial squamous cell carcinomas[J]. Cancer Genet Cytogenet, 1999, 112(1):26-33.
  • 3[3]Herman JG, Graff JR, Myohanen S, et al.Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands[J]. Proc Natl Acad Sci U S A, 1996, 93(18):9821-9826.
  • 4[4]Akama Y, Yasui W, Kuniyasu H, et al. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines[J]. Jpn J Cancer Res, 1996, 87(8):824-830.
  • 5[5]Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers[J]. Cancer Res, 1995, 55(20):4525-4530.
  • 6[6]Sakata K, Tamura G, Maesawa C, et al. Loss of heterozygosity on the short arm of chromosome 9 without p16 gene mutation in gastric carcinomas[J]. Jpn J Cancer Res, 1995, 86(4):333-335.
  • 7[7]Merlo A, Herman JG, Mao L, et al. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers[J]. Nat Med, 1995, 1(7):686-692.
  • 8[8]Lee YY, Kang SH, Seo JY, et al.Alterations of p16INK4A and p15INK4B genes in gastric carcinomas[J]. Cancer, 1997, 80(10):1889-1896.
  • 9[9]Toyota M, Ahuja N, Suzuki H, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype[J]. Cancer Res, 1999, 59(21):5438-5442.
  • 10Mi K,Dolan PJ,Johnson GV.The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity[J].J Biol Chem,2006,281 (8):4787 -4794.

共引文献19

同被引文献90

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部